Free Trial

LSV Asset Management Boosts Holdings in Centene Co. (NYSE:CNC)

Centene logo with Medical background
Remove Ads

LSV Asset Management grew its position in Centene Co. (NYSE:CNC - Free Report) by 17.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,279,433 shares of the company's stock after purchasing an additional 480,082 shares during the quarter. LSV Asset Management owned about 0.65% of Centene worth $198,668,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Capital Advisors Ltd. LLC grew its position in Centene by 75.3% during the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock worth $25,000 after purchasing an additional 177 shares during the last quarter. Hurley Capital LLC acquired a new position in shares of Centene in the 4th quarter valued at about $26,000. Rialto Wealth Management LLC purchased a new stake in Centene in the 4th quarter worth approximately $30,000. OFI Invest Asset Management acquired a new stake in Centene during the fourth quarter valued at $33,000. Finally, SRS Capital Advisors Inc. grew its position in shares of Centene by 73.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company's stock valued at $38,000 after acquiring an additional 267 shares during the period. Institutional investors and hedge funds own 93.63% of the company's stock.

Centene Stock Down 1.4 %

Shares of NYSE:CNC traded down $0.92 during trading on Monday, hitting $62.94. The company's stock had a trading volume of 3,104,770 shares, compared to its average volume of 4,695,219. Centene Co. has a fifty-two week low of $55.03 and a fifty-two week high of $80.59. The business has a 50 day moving average price of $59.49 and a two-hundred day moving average price of $61.65. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11. The company has a market capitalization of $31.22 billion, a PE ratio of 10.09, a P/E/G ratio of 0.80 and a beta of 0.53.

Remove Ads

Centene (NYSE:CNC - Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.31. Centene had a return on equity of 13.85% and a net margin of 2.03%. The company had revenue of $40.81 billion for the quarter, compared to the consensus estimate of $38.78 billion. During the same quarter in the prior year, the business earned $0.45 EPS. Centene's revenue was up 3.4% on a year-over-year basis. As a group, research analysts expect that Centene Co. will post 6.86 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently commented on CNC. Guggenheim began coverage on shares of Centene in a report on Wednesday, April 9th. They issued a "neutral" rating for the company. JPMorgan Chase & Co. reissued an "overweight" rating and issued a $75.00 price objective (down previously from $80.00) on shares of Centene in a report on Tuesday, December 17th. Wells Fargo & Company decreased their target price on shares of Centene from $76.00 to $72.00 and set an "overweight" rating on the stock in a report on Friday, February 14th. Argus lowered shares of Centene from a "buy" rating to a "hold" rating in a research report on Thursday, February 6th. Finally, StockNews.com upgraded Centene from a "buy" rating to a "strong-buy" rating in a research report on Friday. Seven research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $80.85.

Check Out Our Latest Stock Report on CNC

Centene Company Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Featured Articles

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Donald Trump Owns These 7 Stocks, Should You?

Donald Trump Owns These 7 Stocks, Should You?

He’s one of the most talked-about billionaires in the world—but when it comes to investing, Donald Trump’s stock picks are shockingly… low-key.

Related Videos

Donald Trump Owns These 7 Stocks, Should You?
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Quantum Stocks Are Heating Up Again — 7 to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads